ArthroCare Stock Hits New 52-Week Low (ARTC)

NEW YORK (TheStreet) -- ArthroCare Corporation (Nasdaq:ARTC) hit a new 52-week low Monday as it is currently trading at $26.20, below its previous 52-week low of $26.27 with 125,343 shares traded as of 3:09 p.m. ET. Average volume has been 150,300 shares over the past 30 days.

ArthroCare has a market cap of $754.4 million and is part of the health care sector and health services industry. Shares are down 14% year to date as of the close of trading on Friday.

ArthroCare Corporation, a medical device company, develops, manufactures, and markets surgical products primarily based on its minimally invasive patented Coblation technology. The company has a P/E ratio of 28, above the average health services industry P/E ratio of 27.7 and above the S&P 500 P/E ratio of 17.7.

Sign up for TheStreet's FREE Dividend and Income Investor Newsletter

TheStreet Ratings rates ArthroCare as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and disappointing return on equity. You can view the full ArthroCare Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

 

For more information on ArthroCare Corporation click any of the following:

• ArthroCare Corporation Stock Price

• ArthroCare Corporation Analyst Ratings

• ArthroCare Corporation Key Stats & Profile

• ArthroCare Corporation Earnings

• ArthroCare Corporation Ratio Comparison

• ArthroCare Corporation Growth Rates

• ArthroCare Corporation Balance Sheet

• ArthroCare Corporation Cash Flow

• ArthroCare Corporation Income Statement